Q3 2021 13F Holders as of 9/30/2021
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
67.6M
-
Number of holders
-
329
-
Total 13F shares, excl. options
-
61.2M
-
Shares change
-
+2.21M
-
Total reported value, excl. options
-
$7.3B
-
Value change
-
+$275M
-
Put/Call ratio
-
0.92
-
Number of buys
-
175
-
Number of sells
-
-138
-
Price
-
$119.38
Significant Holders of TANDEM DIABETES CARE INC - Common Stock, par value $0.001 per share (TNDM) as of Q3 2021
383 filings reported holding TNDM - TANDEM DIABETES CARE INC - Common Stock, par value $0.001 per share as of Q3 2021.
TANDEM DIABETES CARE INC - Common Stock, par value $0.001 per share (TNDM) has 329 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 61.2M shares
of 67.6M outstanding shares and own 90.49% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (6.05M shares), FMR LLC (5.85M shares), BlackRock Inc. (5.81M shares), Jackson Square Partners, LLC (3.57M shares), Capital World Investors (3.29M shares), Invesco Ltd. (1.74M shares), STATE STREET CORP (1.61M shares), Champlain Investment Partners, LLC (1.49M shares), BROWN CAPITAL MANAGEMENT LLC (1.22M shares), and RTW INVESTMENTS, LP (1.16M shares).
This table shows the top 329 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.